About PRIVO TECHNOLOGIES, INC.
Privo Technologies, Inc. is a biotechnology company focused on developing innovative therapeutics for cancer treatment, with a mission to provide safer and more accessible treatment options for patients. Their PRV™ platform enables targeted therapy with multiple dosage forms for various cancer indications.
Development of targeted cancer therapeutics using nanotechnologyCreation of topical and intraoperatively administered patches, hydrogels, and intratumoral injectablesPhase II and Phase III clinical trials for PRV111, PRV131, and PRV211Collaboration with FDA, NCI, and NIDCR for product development and clinical trials
Recent Federal Awards
| Award | Agency | Amount | Date |
|---|---|---|---|
| TOPIC TITLE: CANCER TREATMENT TECHNOLOGIES FOR LOW-RESOURCE SETTINGS PROJECT TITLE: PRV311: A STANDALONE, SAFE | Department of Health and Human Services | $2.0M |
Is this your company?
Claim this profile to keep it accurate — and see the federal & state opportunities GovIntel's AI has matched to PRIVO TECHNOLOGIES, INC. right now.
Claim this profile See matched opportunitiesData compiled from public government sources including SAM.gov, USAspending.gov, and state procurement records. Last verified against federal award records. Inaccurate? Let us know.